Lyra Therapeutics, Inc. - Common Stock (LYRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LYRA on Nasdaq
Shares outstanding
1,769,273
Price per share
$3.59
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
448,588
Total reported value
$2,933,978
% of total 13F portfolios
0%
Share change
-45,103
Value change
-$323,578
Number of holders
25
Price from insider filings
$3.59
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyra Therapeutics, Inc. - Common Stock (LYRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 9.9% $628,817 175,158 SABBY MANAGEMENT, LLC 31 Dec 2025

As of 30 Sep 2025, 25 institutional investors reported holding 448,588 shares of Lyra Therapeutics, Inc. - Common Stock (LYRA). This represents 25% of the company’s total 1,769,273 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lyra Therapeutics, Inc. - Common Stock (LYRA) together control 25% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PERCEPTIVE ADVISORS LLC 13% 229,382 -10% 0.04% $1,497,864
SABBY MANAGEMENT, LLC 7.2% 127,624 +1.5% 4.3% $832,874
VANGUARD GROUP INC 1.6% 28,754 -1.5% 0% $189,489
Ikarian Capital, LLC 1.2% 21,161 0% 0.03% $139,452
CITADEL ADVISORS LLC 1.1% 19,484 0% $128,400
GEODE CAPITAL MANAGEMENT, LLC 0.62% 10,986 0% 0% $72,412
UBS Group AG 0.23% 4,001 +199950% 0% $26,111
BlackRock, Inc. 0.1% 1,690 0% 0% $11,029
ROYAL BANK OF CANADA 0.07% 1,325 +20% 0% $9,000
MORGAN STANLEY 0.07% 1,277 -41% 0% $8,335
CITIGROUP INC 0.04% 705 -11% 0% $4,646
Tower Research Capital LLC (TRC) 0.03% 534 -64% 0% $3,485
FMR LLC 0.02% 406 -77% 0% $2,676
Signature Resources Capital Management, LLC 0.02% 400 0% 0% $2,610
EverSource Wealth Advisors, LLC 0.02% 345 -3.6% 0% $2,251
JONES FINANCIAL COMPANIES LLLP 0.01% 210 +2000% 0% $1,359
Fortitude Family Office, LLC 0.01% 96 0% $627
SBI Securities Co., Ltd. 0% 80 -5.9% 0% $522
JPMORGAN CHASE & CO 0% 27 -86% 0% $178
COMERICA BANK 0% 23 0% 0% $150
OSAIC HOLDINGS, INC. 0% 22 0% $143
Wilmington Savings Fund Society, FSB 0% 20 0% $131
BANK OF AMERICA CORP /DE/ 0% 18 -100% 0% $117
BNP PARIBAS FINANCIAL MARKETS 0% 16 0% 0% $104
IFP Advisors, Inc 0% 2 -67% 0% $13

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock (LYRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$3,237 $3.59 0
2025 Q3 448,588 $2,933,978 -$323,578 $6.53 25
2025 Q2 493,700 $4,423,417 +$4,423,193 $8.96 29